[
  {
    "ts": "2025-06-16T13:20:37+00:00",
    "headline": "Sector Update: Health Care Stocks Flat to Higher Premarket Monday",
    "summary": "Health care stocks were flat to higher premarket Monday with the Health Care Select Sector SPDR Fund",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-flat-132037334.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "febeb1c6-6a32-326e-a996-39088b13ae0d",
      "content": {
        "id": "febeb1c6-6a32-326e-a996-39088b13ae0d",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Flat to Higher Premarket Monday",
        "description": "",
        "summary": "Health care stocks were flat to higher premarket Monday with the Health Care Select Sector SPDR Fund",
        "pubDate": "2025-06-16T13:20:37Z",
        "displayTime": "2025-06-16T13:20:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-flat-132037334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-flat-132037334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            },
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "SAGE"
            },
            {
              "symbol": "SUPN"
            },
            {
              "symbol": "QGEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-16T12:27:00+00:00",
    "headline": "QGEN Stock Rises in After Market Following Partnership With Incyte",
    "summary": "QIAGEN teams up with Incyte to develop NGS-based companion diagnostics for blood cancers.",
    "url": "https://finance.yahoo.com/news/qgen-stock-rises-market-following-122700457.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9958b548-33b2-32c6-901c-41b3d60ec369",
      "content": {
        "id": "9958b548-33b2-32c6-901c-41b3d60ec369",
        "contentType": "STORY",
        "title": "QGEN Stock Rises in After Market Following Partnership With Incyte",
        "description": "",
        "summary": "QIAGEN teams up with Incyte to develop NGS-based companion diagnostics for blood cancers.",
        "pubDate": "2025-06-16T12:27:00Z",
        "displayTime": "2025-06-16T12:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AeEW5pB2gJm.pEvDGN7i.A--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/18pxvSkCeCQtGDRu2e7mfw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/qgen-stock-rises-market-following-122700457.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/qgen-stock-rises-market-following-122700457.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QGEN"
            },
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-16T11:06:54+00:00",
    "headline": "Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms",
    "summary": "The partnership focuses on supporting Incyte's investigational therapies, including its monoclonal antibody.",
    "url": "https://www.medicaldevice-network.com/news/qiagen-incyte-diagnostic/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "481b6110-cd8a-3a28-8e05-c4e3b062dc87",
      "content": {
        "id": "481b6110-cd8a-3a28-8e05-c4e3b062dc87",
        "contentType": "STORY",
        "title": "Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms",
        "description": "",
        "summary": "The partnership focuses on supporting Incyte's investigational therapies, including its monoclonal antibody.",
        "pubDate": "2025-06-16T11:06:54Z",
        "displayTime": "2025-06-16T11:06:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/bdc8d911cf6cc8d15a81b8a5ce106579",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Qiagen will create a multimodal panel leveraging next-generation sequencing. Credit: MacroEcon / Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Sio4e7gjiAkRNRuYToZUQ--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/bdc8d911cf6cc8d15a81b8a5ce106579.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jVlQj8TQwGQe7fMdYakNyg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/bdc8d911cf6cc8d15a81b8a5ce106579.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/qiagen-incyte-diagnostic/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/qiagen-incyte-develop-diagnostic-panel-110654878.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QGEN"
            },
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-16T07:44:18+00:00",
    "headline": "Incyte Says 86% of Blood Cancer Patients Responsive to Higher Doses of Drug Candidate",
    "summary": "Incyte (INCY) said Sunday that data from two studies of its monoclonal antibody treatment INCA033989",
    "url": "https://finance.yahoo.com/news/incyte-says-86-blood-cancer-074418768.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "ec372326-b3d5-3660-a280-23c7fcd0ebc8",
      "content": {
        "id": "ec372326-b3d5-3660-a280-23c7fcd0ebc8",
        "contentType": "STORY",
        "title": "Incyte Says 86% of Blood Cancer Patients Responsive to Higher Doses of Drug Candidate",
        "description": "",
        "summary": "Incyte (INCY) said Sunday that data from two studies of its monoclonal antibody treatment INCA033989",
        "pubDate": "2025-06-16T07:44:18Z",
        "displayTime": "2025-06-16T07:44:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-says-86-blood-cancer-074418768.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-says-86-blood-cancer-074418768.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]